Alnylam Pharmaceuticals Inc (ALNY)

06:02 AM

What does recent volatility data suggest for Alnylam Pharmaceuticals Inc.Earnings Growth Summary & Daily Technical Forecast Reports - Newser

06:02 AM

01:03 AM

What’s the recovery path for long term holders of Alnylam Pharmaceuticals Inc.Trend Reversal & Capital Protection Trade Alerts - Newser

01:03 AM

12:39 PM

Alnylam’s ConTTRibute Study: A Closer Look at Real-World Impact on ATTR Amyloidosis - TipRanks

12:39 PM

12:38 PM

Alnylam’s ALN-APP Study: A Promising Step in Alzheimer’s Treatment - TipRanks

12:38 PM

12:37 PM

Alnylam’s Patisiran-LNP Study: Key Insights for Investors - TipRanks

12:37 PM

12:37 PM

Alnylam’s ALN-HTT02 Study: A Potential Game-Changer for Huntington’s Disease - TipRanks

12:37 PM

12:33 PM

Alnylam’s Innovative Approach in Liver Cancer Treatment: A Phase 1 Study Update - TipRanks

12:33 PM

11:58 AM

Best data tools to analyze Alnylam Pharmaceuticals Inc. stockEarnings Overview Report & Community Consensus Stock Picks - Newser

11:58 AM

10:30 AM

What moving averages say about Alnylam Pharmaceuticals Inc.Market Volume Summary & High Conviction Buy Zone Picks - Newser

10:30 AM

09:09 AM

What’s next for Alnylam Pharmaceuticals Inc. stock priceWeekly Trend Summary & Comprehensive Market Scan Insights - Newser

09:09 AM

08:00 AM

Leading RNAi Therapeutics Company Alnylam Set for Key September Healthcare Conference Circuit - Stock Titan

08:00 AM

07:44 AM

Applying big data sentiment scoring on Alnylam Pharmaceuticals Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser

07:44 AM

06:53 AM

Will Alnylam Pharmaceuticals Inc. outperform the marketJuly 2025 Patterns & Smart Swing Trading Techniques - Newser

06:53 AM

06:48 AM

Measuring Alnylam Pharmaceuticals Inc.’s beta against major indicesLong Setup & Accurate Technical Buy Alerts - Newser

06:48 AM

06:47 AM

Can trapped investors hope for a rebound in Alnylam Pharmaceuticals Inc.July 2025 Intraday Action & Low Drawdown Investment Strategies - Newser

06:47 AM

03:28 AM

Real time breakdown of Alnylam Pharmaceuticals Inc. stock performance2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser

03:28 AM

02:30 AM

Published on: 2025-08-27 01:30:17 - Newser

02:30 AM

01:57 AM

Quantitative breakdown of Alnylam Pharmaceuticals Inc. recent moveBear Alert & Accurate Buy Signal Notifications - Newser

01:57 AM

12:33 PM

Market reaction to Alnylam Pharmaceuticals Inc.’s recent newsChart Signals & Community Trade Idea Sharing Platform - Newser

12:33 PM

Aug 26, 2025

Leading vs lagging indicators on Alnylam Pharmaceuticals Inc. performanceWeekly Profit Recap & Verified Trade Idea Suggestions - Newser

Aug 26, 2025

Aug 26, 2025

Earnings visualization tools for Alnylam Pharmaceuticals Inc.Insider Buying & Comprehensive Market Scan Insights - Newser

Aug 26, 2025

Aug 26, 2025

Can Alnylam Pharmaceuticals Inc. hit a new high this month2025 Valuation Update & High Conviction Buy Zone Alerts - Newser

Aug 26, 2025

Aug 26, 2025

Intraday pattern recognizer results for Alnylam Pharmaceuticals Inc.Trade Performance Summary & Comprehensive Market Scan Reports - Newser

Aug 26, 2025

Aug 26, 2025

Regeneron's cemdisiran hits phase III endpoints in myasthenia gravis - BioWorld MedTech

Aug 26, 2025

Aug 26, 2025

Short interest data insights for Alnylam Pharmaceuticals Inc.Quarterly Portfolio Review & Entry Point Confirmation Signals - Newser

Aug 26, 2025

Aug 26, 2025

How to build a custom watchlist for Alnylam Pharmaceuticals Inc.2025 Top Gainers & Community Verified Trade Signals - Newser

Aug 26, 2025

Aug 26, 2025

Alnylam Pharmaceuticals Inc. stock volume spike explainedJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser

Aug 26, 2025

Aug 26, 2025

Chart overlay techniques for tracking Alnylam Pharmaceuticals Inc.July 2025 Setups & Stepwise Trade Signal Implementation - Newser

Aug 26, 2025

Aug 26, 2025

RNA drug from Regeneron, Alnylam succeeds in rare autoimmune disease trial - BioPharma Dive

Aug 26, 2025

Aug 26, 2025

Regeneron posts late-stage trial win for myasthenia gravis drug developed with Alnylam - Seeking Alpha

Aug 26, 2025

Aug 26, 2025

Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis - GlobeNewswire Inc.

Aug 26, 2025

Aug 26, 2025

How sentiment analysis helps forecast Alnylam Pharmaceuticals Inc.Trade Performance Summary & Daily Market Momentum Tracking - Newser

Aug 26, 2025

Aug 26, 2025

Scenic Enters License and Research Agreement with Alnylam - GlobeNewswire

Aug 26, 2025

Aug 25, 2025

Alnylam Rebounds on Analyst Upgrades and Institutional Buys Despite 139th Trading Volume Rank - AInvest

Aug 25, 2025

Aug 25, 2025

Applying chart zones and confluence areas to Alnylam Pharmaceuticals Inc.July 2025 Action & Fast Exit and Entry Strategy Plans - Newser

Aug 25, 2025

Aug 25, 2025

Risk adjusted return profile for Alnylam Pharmaceuticals Inc. analyzedEarnings Beat & Risk Managed Investment Entry Signals - Newser

Aug 25, 2025

Aug 24, 2025

Alnylam Pharmaceuticals Inc. Pullback Analyzed — Is It Time to Exit2025 Volatility Report & Target Return Focused Picks - beatles.ru

Aug 24, 2025

Aug 24, 2025

What does recent volatility data suggest for Alnylam Pharmaceuticals IncMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser

Aug 24, 2025

Aug 23, 2025

Will breakout in Alnylam Pharmaceuticals Inc. lead to full recoveryPortfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser

Aug 23, 2025

Aug 23, 2025

Moving Average Crossover Confirms Uptrend in Alnylam Pharmaceuticals Inc.2025 Top Decliners & Real-Time Volume Analysis - beatles.ru

Aug 23, 2025